Growing Prevalence Of Diabetes Fuelling The Growth Of The Market Due To Increasing Need For Continuous Glucose Management: The Driving Engine Behind Insulin Infusion Pump Market Evolution in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Insulin Infusion Pump Market Size Growth Forecast: What to Expect by 2025?
The expanding insulin infusion pump sector has experienced noteworthy upward momentum lately, projected to shift from a valuation of $6.33 billion in the year 2024 up to $6.93 billion by 2025, reflecting a compound annual growth rate of 9.6%. This robust expansion during the preceding timeframe is largely attributable to several key factors: the escalating frequency and broader presence of individuals diagnosed with diabetes, the concurrent rise in obesity rates, a heightened consumer requirement for sophisticated, integrated delivery mechanisms, greater public knowledge and educational outreach concerning these technologies, and enhancements within established reimbursement frameworks.

How Will the Insulin Infusion Pump Market Size Evolve and Grow by 2029?
Anticipation suggests substantial expansion for the insulin infusion pump market across coming years, projecting a valuation of $10.18 billion by 2029, driven by a compound annual growth rate (CAGR) reaching 10.1%. This upward trajectory throughout the projection timeframe stems from several factors, including the broader availability of remote healthcare options, the proliferation of long-term health conditions, a heightened desire for tailored medical treatments, escalations in spending on medical care, along with greater comprehension among both medical professionals and individuals utilizing insulin. Key developments shaping this market during the forecasted period involve progress in fully automated systems, the incorporation of AI and machine learning capabilities, leaps forward in wireless communication technology, innovations in making pumps smaller, and better linking them with personal monitoring devices.

View the full report here:
https://www.thebusinessresearchcompany.com/report/insulin-infusion-pump-global-market-report

What Drivers Are Propelling the Growth of Insulin Infusion Pump Market Forward?
Anticipated future expansion within the insulin infusion pump sector is fueled by the increasing incidence of diabetes, a persistent ailment characterized by the body's failure to correctly manage blood sugar or glucose levels; this heightened prevalence is predominantly attributed to sedentary habits and inadequate nutrition, contributing to rising obesity, insulin resistance, and a greater incidence of type 2 diabetes, whereas these pumps facilitate superior diabetes management through the continuous and exact administration of insulin, ensuring blood glucose stability, thereby minimizing the necessity for multiple daily injections, offering enhanced convenience and superior glycemic control for improved patient care, as underscored by the uptake in related conditions, exemplified when the UK's National Health Service reported in June 2024 that registered GP patients diagnosed with non-diabetic hyperglycemia or pre-diabetes escalated to 3,615,330 in 2023, an 18% jump from the 3,065,825 figures recorded in 2022, consequently suggesting that the rise in ailments linked to lifestyle factors will boost the market for medical device safety assessments.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24256&type=smp

Which Emerging Trends Are Transforming the Insulin Infusion Pump Market in 2025?
Key players within the insulin infusion pumps sector are channeling their efforts into creating novel offerings, specifically insulin patch pump technologies, aiming to boost ease of use, increase portability, and deliver a more unobtrusive and comfortable method of insulin administration for individuals requiring it. These patch pump systems entail compact, body-worn apparatuses capable of administering insulin transdermally, thereby eliminating the necessity for customary tubing attachments. Illustratively, in November of 2023, ViCentra BV, a medical technology firm situated in the Netherlands, introduced a hybrid closed-loop configuration designed for automated insulin administration, which merges their Kaleido insulin patch pump with the Diabeloop DBLG1 computational logic and the Dexcom G6 system for ongoing glucose surveillance. This synthesized artificial pancreas autonomously modifies insulin dosages as situations demand, substantially mitigating episodes of low blood sugar while concurrently refining glycemic regulation and the duration spent within the target glucose range for those afflicted with type 1 diabetes. Furthermore, the apparatus boasts an intuitive design, demanding very little preliminary configuration apart from foregoing routine finger-prick assessments, and features the capability to transmit collected metrics to a remote storage capacity enabling effortless oversight by both the patients and medical professionals attending to them.

What Are the Key Segments in the Insulin Infusion Pump Market?
The insulin infusion pumpmarket covered in this report is segmented -

1) By Type: Continuous Subcutaneous Insulin Infusion Pumps; Insulin Delivery Pens; Wearable Insulin Pumps
2) By Technology: Remote Monitoring Systems; Closed Loop Systems; Smart Insulin Pumps
3) By End Use: Hospitals; Home Care Settings; Diabetes Clinics

Subsegments:
1) By Continuous Subcutaneous Insulin Infusion (CSII) Pumps: Tubed Insulin Pumps; Tubeless Insulin Pumps; Closed-Loop Systems; Smart Insulin Pumps
2) By Insulin Delivery Pens: Reusable Insulin Pens; Disposable Insulin Pens; Smart Insulin Pens
3) By Wearable Insulin Pumps: Adhesive Patch Pumps; Detachable Patch Pumps; Hybrid Closed-Loop Wearables

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24256&type=smp

Who Are the Key Players Shaping the Insulin Infusion Pump Market's Competitive Landscape?
Major companies operating in the insulin infusion pump market are Pfizer Inc., Roche Holding AG, Sanofi S.A., Medtronic plc, Eli Lilly and Company, Becton, dic*kinson and Company, Baxter International Inc., Terumo Corporation, Smiths Group plc, Moog Inc., ICU Medical Inc., Insulet Corporation, MicroPort Scientific Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, B. Braun Melsungen AG, Beta Bionics Inc., SOOIL Development Co. Ltd., Fresenius SE & Co. KGaA, Shinmyung Mediyes Co. Ltd.

What Geographic Markets Are Powering Growth in the Insulin Infusion Pump Market?
North America was the largest region in the insulin infusion pump market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin infusion pump market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24256

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.